The choice of controls in a case-control study on WBC-DNA adducts and metabolic polymorphisms

Biomarkers

Volumn 5, Issue 4, 2000, Pages 307-313

  Sacerdote, Carlotta ^a   Peluso, Marco ^b   Munnia, Armelle ^b   Malaveille, Christian ^c   Vineis, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Case control study; DNA adducts; Metabolic polymorphisms; Molecular epidemiology

Indexed keywords

POLYCYCLIC AROMATIC COMPOUND;

ADULT; AGED; ARTICLE; BLADDER CANCER; CASE CONTROL STUDY; CHRONIC GASTRITIS; CONTROLLED STUDY; DIETARY INTAKE; DNA ADDUCT; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; LEUKOCYTE; MAJOR CLINICAL STUDY; METABOLISM;

EID: 0033883599     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475000413854     Document Type: Article

References (17)

1. ALBERT, R. E., MILLER, M. L., CODY, T. E., TALASKA, G., UNDERWOOD, P. and ANDRINGA, A. 1996, Epidermal cytokinetics, DNA adducts, and dermal inflammation in the mouse skin in response to repeated benzo(a)pyrene exposures. Toxicology and Applied Pharmacology, 136, 67-74.
2. BARTSCH, H., MALAVEILLE, C., LOWENFELS, A. B., MAISONNEUVE, P., HAUTEFEUILLE, A., BOYLE, P. and INTERNATIONAL PANCREATIC DISEASE STUDY GROUP 1998, Genetic polymorphisms of N-acetyltransferases, glutathione-S-transferase M1 and NAD(P)H: quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. European Journal of Cancer Prevention, 7,215-223.
3. BELL, D. A., TAYLOR, J. A., BUTLER, M. A., STEPHENS, E. A., WIEST, J., BRUBAKER, D. H., KADLUBAR, F. F. and LUCIER, G. W. 1993, Genotype/phenotype discordance for human N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis, 14, 1689-1692.
4. BERKSON, J. 1946, Limitations of the application of 4-fold tables to hospital data. Biomet. Bull., 2, 47-53.
5. BORM, P. J., KNAAPEN, A. M., SCHINS, R. P., GODSCHALK, R. W. and SCHOOTEN, F. J. 1997, Neutrophils amplify the formation of DNA adducts by benzo(a)pyrene in lung target cells. Environmental Health Perspectives, 105 (suppl. 5), 1089-1093.
6. D'ERRICO, A., TAIOLI, E., CHEN, X. and VINEIS, P. 1996, Genetic metabolic polymorphisms and risk of cancer: a review of the literature. Biomarkers, 1, 149-1 73.
7. DOLL, R. and PETO, R. 1978, Cigarette smoking and bronchial carcinoma among regular cigarette smokers and life-long-non smokers. Journal of Epidemiology and Community Health, 32, 303-313.
8. FRYER, A. A., ZHAO, L., ALLDERSEA, J., PEARSON, W. R. and STRANGE, R. C. 1993, Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1A, GSTM1B, GSTM1A,B and GSTM1 null polymorphisms of the glutathione-S-transferase GSTM1 locus. Biochemical Journal, 295, 313-315.
9. HENNEKENS, C. H. and BURING, J. E. 1987, Epidemiology in Medicine (Boston: Little, Brown and Co.).
10. KELSEY, T. K., HANKINSON, S. E., COLDITZ, G. A. et al. 1997, Glutathione-S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. Cancer Epidemiology Biomarkers and Prevention, 6, 511-516.
11. OKKELS, H., SIGSGAARD, T., WOLF, H. and AUTRUP, H. 1996, Glutathione-S-transferase mu as a risk factor in bladder cancer. Pharmacogenetics, 3, 251-256.
12. 32P-Postlabeling detection of DNA adducts in peripheral white blood cells of greenhouse floriculturists from Western Liguria, Italy. Cancer Epidemiology, Biomarkers and Prevention, 5, 361-369.
13. PELUSO, M., AIROLDI, L., MUNNIA, A., MARTONE, T., CODA, R., MALAVEILLE, C., GIACOMELLI. G., TERRONE, C., CASETTA, G. and VINEIS, P. 1998, White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study. Cancer Epidemiology, Biomarkers and Prevention, 7, 341-346.
14. PEMBLE, S., SCHROEDER, K. R., SPENCER, S. R., MEYER, D. J., HALLIER, E., BOLT, H. M., KETTERER, B. and TAYLOR, J. B. 1994, Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochemical Journal, 300, 271-276.
15. ROSVOLD, E. A., McGLYNN, K. A., LUSTBADER, E. D. and BUETOW, K. H. 1995, Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics, 5, 199-206.
16. ROTHMAN, N., STEWART, W. F. and SCHULTE, P. A. 1995, Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiology, Biomarkers and Prevention, 4, 301-311.
17. ZIMNIAK, P., NANDURI, B., PIKULA, S., BANDOROWIEZ-PIKULA, J., SINGHAL, S. S., SRIVASTAVA, S. K., AWASTHI, S. and AWASTHI, Y. C. 1994, Naturally-occurring human glutathoine S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymatic properties. European Journal of Biochemistry, 244, 893-899.